West Pharmaceutical Services (WST)
Health Care · Pharmaceutical packaging and injectable drug delivery systems
Global leader in injectable drug containment and delivery systems serving biopharmaceutical and medical device manufacturers with primary packaging, drug delivery devices, and contract manufacturing.
What West Pharmaceutical Services does
West Pharmaceutical Services designs and manufactures technologically advanced containment and delivery systems for injectable drugs and healthcare products. The company operates through two segments: Proprietary Products (elastomeric stoppers, seals, syringes, cartridges, vials, self-injection devices, and integrated solutions) and Contract-Manufactured Products (custom devices for pharmaceutical, diagnostic, and medical device applications). With facilities across North America, Europe, and Asia, West serves leading biologic, generic, pharmaceutical, and medical device companies globally, generating 56.7% of sales outside the U.S.
Themes: ["injectable drug delivery","biopharmaceutical packaging","drug containment solutions","patient adherence technologies","medical device manufacturing","cold chain storage","drug compatibility","connected health technologies"]
Fundamentals
- Price$353.68 as of 2026-07-08 close
- Market cap$24.9B as of 2026-07-09
- 1-year return+60.4% as of 2026-07-08 close
- P/E45.85 as of 2026-07-09
- Net margin+16.9% as of 2026-07-09
- Gross margin+36.3% as of 2026-07-09
- ROE+17.9% as of 2026-07-09
- Debt / equity0.07 as of 2026-07-09
- Revenue growth (YoY)+11.2% as of 2026-07-09
- Revenue CAGR (3y)+2.1% SEC XBRL
- Beta1.13 as of 2026-07-09
Dividend: yield +0.3%; 5-year non-decreasing per-share dividend streak (SEC XBRL).
Key risks (from latest filing)
["Currency fluctuations from significant international operations (56.7% of sales outside U.S.) exposed to multiple tax jurisdictions and FX volatility","Dependence on elastomers, aluminum, and plastic raw materials subject to supply chain disruptions and commodity price fluctuations","Complex regulatory requirements and quality standards for pharmaceutical and medical device markets requiring continuous compliance investment"]
Competitors & peers
- Gerresheimer AG (elastomers and pharmaceutical packaging)
- Schott AG (glass and plastic pharmaceutical containers)
- Nippon Glass (pharmaceutical packaging)
- Daikyo Seiko (elastomers for pharma)
- Aptar Group (drug delivery and primary packaging)
- Steriject (injectable device manufacturing)
Fundamentals: Finnhub, as of 2026-07-09. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.